Lack of correlation between SREBF1 genotype and hyperlipidemia in individuals treated with highly active antiretroviral therapy

被引：12
作者：
Yang, AM [1 ]
King, MS [1 ]
Han, LX [1 ]
Isaacson, JD [1 ]
Mueller, T [1 ]
Grimm, DR [1 ]
Brun, SC [1 ]
Katz, DA [1 ]
机构：
[1] Abbott Labs, Antiviral Global Project Team, Abbott Pk, IL 60064 USA
来源：
AIDS | 2003年 / 17卷 / 14期
关键词：
D O I：
10.1097/00002030-200309260-00024
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：2142 / 2143
页数：2
相关论文
共 4 条
  • [1] The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor
    Brown, MS
    Goldstein, JL
    [J]. CELL, 1997, 89 (03) : 331 - 340
  • [2] Replication validity of genetic association studies
    Ioannidis, JPA
    Ntzani, EE
    Trikalinos, TA
    Contopoulos-Ioannidis, DG
    [J]. NATURE GENETICS, 2001, 29 (03) : 306 - 309
  • [3] A single-nucleotide polymorphism in the sterol-regulatory element-binding protein 1c gene is predictive of HIV-related hyperlipoproteinaemia
    Miserez, AR
    Muller, PY
    Barella, L
    Schwietert, M
    Erb, P
    Vernazza, PL
    Battegay, M
    [J]. AIDS, 2001, 15 (15) : 2045 - 2049
  • [4] Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection
    Walmsley, S
    Bernstein, B
    King, M
    Arribas, J
    Beall, G
    Ruane, P
    Johnson, M
    Johnson, D
    Lalonde, R
    Japour, A
    Brun, S
    Sun, E
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (26) : 2039 - 2046
1